# Summit Biosciences Inc. – FDA Inspection, Sep 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/4dfd068f-13de-4321-897b-877c72d3592b
Source feed: FDA_Inspections

> FDA inspection 1218227 of Summit Biosciences Inc., September 14, 2023. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218227
- Company Name: Summit Biosciences Inc.
- Inspection Date: 2023-09-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Compliance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Citation Count: 0

## Related Documents

- [FDA Inspection 1261583 - 2025-02-21](https://www.keypedia.com/records/fda_inspections/summit-biosciences-inc/fbf78c84-7d7e-4694-9f67-ee101159342d)
- FDA Inspection 1121348 - 2020-02-04
- FDA Inspection 1018004 - 2017-06-23
- FDA Inspection 933643 - 2015-06-18
- FDA Inspection 868633 - 2014-02-28

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/talmane-j-fisher/f69c101f-fbc7-4ca1-a6d1-1e25450c52b7)

Company: https://www.keypedia.com/companies/summit-biosciences-inc/2dadddc5-06ce-43be-914b-1b6e9a76e976
